cbdMD, Inc. (YCBD)
0.374
-0.02
(-4.69%)
USD |
NYAM |
Nov 13, 16:00
0.3799
+0.01
(+1.58%)
After-Hours: 06:40
cbdMD Enterprise Value : 4.254M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 4.254M |
| November 12, 2026 | 4.459M |
| November 11, 2026 | 4.488M |
| November 10, 2026 | 4.362M |
| November 09, 2026 | 4.332M |
| November 06, 2026 | 4.721M |
| November 05, 2026 | 4.410M |
| November 04, 2026 | 4.610M |
| November 03, 2026 | 4.754M |
| November 02, 2026 | 4.506M |
| October 30, 2026 | 4.351M |
| October 29, 2026 | 4.409M |
| October 28, 2026 | 4.221M |
| October 27, 2026 | 4.210M |
| October 26, 2026 | 4.152M |
| October 23, 2026 | 4.127M |
| October 22, 2026 | 4.241M |
| October 21, 2026 | 4.308M |
| October 20, 2026 | 4.402M |
| October 19, 2026 | 3.966M |
| October 16, 2026 | 4.054M |
| October 15, 2026 | 4.097M |
| October 14, 2026 | 4.020M |
| October 13, 2026 | 4.043M |
| October 12, 2026 | 4.056M |
| Date | Value |
|---|---|
| October 09, 2026 | 4.431M |
| October 08, 2026 | 4.485M |
| October 07, 2026 | 4.621M |
| October 06, 2026 | 4.632M |
| October 05, 2026 | 4.871M |
| October 02, 2026 | 5.166M |
| October 01, 2026 | 5.105M |
| September 30, 2026 | 5.132M |
| September 29, 2026 | 5.310M |
| September 28, 2026 | 5.249M |
| September 25, 2026 | 5.299M |
| September 24, 2026 | 5.199M |
| September 23, 2026 | 5.181M |
| September 22, 2026 | 5.655M |
| September 21, 2026 | 4.988M |
| September 18, 2026 | 5.100M |
| September 17, 2026 | 5.655M |
| September 16, 2026 | 5.277M |
| September 15, 2026 | 5.211M |
| September 14, 2026 | 5.400M |
| September 11, 2026 | 5.457M |
| September 10, 2026 | 5.410M |
| September 09, 2026 | 5.565M |
| September 08, 2026 | 5.652M |
| September 04, 2026 | 5.384M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Tilray Brands, Inc. | 483.31M |
| Organogenesis Holdings, Inc. | 291.18M |
| Guardian Pharmacy Services, Inc. | 3.065B |
| ANI Pharmaceuticals, Inc. | 1.807B |
| Corcept Therapeutics, Inc. | 7.615B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.127M |
| Revenue (Quarterly) | 5.554M |
| Total Expenses (Quarterly) | 6.681M |
| EPS Diluted (Quarterly) | -0.1129 |
| Gross Profit Margin (Quarterly) | 50.03% |
| Profit Margin (Quarterly) | -20.30% |
| Earnings Yield | -82.65% |
| Normalized Earnings Yield | -82.65 |